C.Q. Pharmaceutical Holding Co Ltd
C.Q. Pharmaceutical Holding Co., Ltd. engages in the wholesale and retail of medicines and medical devices. The company is involved in the pharmaceutical commerce, warehousing logistics, pharmaceutical industry, and research and development businesses. It also engages in the hospital pure sales, commercial wholesale, retail chain, warehousing logistics, and supply chain value-added services for d… Read more
C.Q. Pharmaceutical Holding Co Ltd (000950) - Total Assets
Latest total assets as of September 2025: CN¥67.71 Billion CNY
Based on the latest financial reports, C.Q. Pharmaceutical Holding Co Ltd (000950) holds total assets worth CN¥67.71 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
C.Q. Pharmaceutical Holding Co Ltd - Total Assets Trend (1996–2024)
This chart illustrates how C.Q. Pharmaceutical Holding Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
C.Q. Pharmaceutical Holding Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
C.Q. Pharmaceutical Holding Co Ltd's total assets of CN¥67.71 Billion consist of 86.2% current assets and 13.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 14.1% |
| Accounts Receivable | CN¥36.08 Billion | 54.2% |
| Inventory | CN¥9.98 Billion | 15.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥369.05 Million | 0.6% |
| Goodwill | CN¥1.46 Billion | 2.2% |
Asset Composition Trend (1996–2024)
This chart illustrates how C.Q. Pharmaceutical Holding Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: C.Q. Pharmaceutical Holding Co Ltd's current assets represent 86.2% of total assets in 2024, an increase from 53.0% in 1996.
- Cash Position: Cash and equivalents constituted 14.1% of total assets in 2024, up from 4.0% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 1996.
- Asset Diversification: The largest asset category is accounts receivable at 54.2% of total assets.
C.Q. Pharmaceutical Holding Co Ltd Competitors by Total Assets
Key competitors of C.Q. Pharmaceutical Holding Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
|
China Meheco Co Ltd
SHG:600056
|
China | CN¥36.99 Billion |
C.Q. Pharmaceutical Holding Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - C.Q. Pharmaceutical Holding Co Ltd generates 1.21x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, C.Q. Pharmaceutical Holding Co Ltd generates $ 0.42 in net profit.
C.Q. Pharmaceutical Holding Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.23 | 1.29 | 1.29 |
| Quick Ratio | 1.02 | 1.06 | 1.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥11.06 Billion | CN¥ 12.93 Billion | CN¥ 7.93 Billion |
C.Q. Pharmaceutical Holding Co Ltd - Advanced Valuation Insights
This section examines the relationship between C.Q. Pharmaceutical Holding Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.86 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 4.9% |
| Total Assets | CN¥66.63 Billion |
| Market Capitalization | $539.38 Million USD |
Valuation Analysis
Below Book Valuation: The market values C.Q. Pharmaceutical Holding Co Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: C.Q. Pharmaceutical Holding Co Ltd's assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for C.Q. Pharmaceutical Holding Co Ltd (1996–2024)
The table below shows the annual total assets of C.Q. Pharmaceutical Holding Co Ltd from 1996 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥66.63 Billion | +4.89% |
| 2023-12-31 | CN¥63.52 Billion | +11.07% |
| 2022-12-31 | CN¥57.19 Billion | +15.07% |
| 2021-12-31 | CN¥49.70 Billion | +17.13% |
| 2020-12-31 | CN¥42.43 Billion | +66.53% |
| 2019-12-31 | CN¥25.48 Billion | +26.67% |
| 2018-12-31 | CN¥20.11 Billion | +32.29% |
| 2017-12-31 | CN¥15.20 Billion | +178.47% |
| 2016-12-31 | CN¥5.46 Billion | -10.30% |
| 2015-12-31 | CN¥6.09 Billion | -10.89% |
| 2014-12-31 | CN¥6.83 Billion | +4.29% |
| 2013-12-31 | CN¥6.55 Billion | +26.36% |
| 2012-12-31 | CN¥5.18 Billion | +19.84% |
| 2011-12-31 | CN¥4.33 Billion | +5.31% |
| 2010-12-31 | CN¥4.11 Billion | +10.15% |
| 2009-12-31 | CN¥3.73 Billion | +49.69% |
| 2008-12-31 | CN¥2.49 Billion | +106.37% |
| 2007-12-31 | CN¥1.21 Billion | +14.76% |
| 2006-12-31 | CN¥1.05 Billion | +7.44% |
| 2005-12-31 | CN¥978.89 Million | +39.65% |
| 2004-12-31 | CN¥700.94 Million | -1.49% |
| 2003-12-31 | CN¥711.52 Million | -21.44% |
| 2002-12-31 | CN¥905.67 Million | -9.15% |
| 2001-12-31 | CN¥996.87 Million | +19.80% |
| 2000-12-31 | CN¥832.11 Million | +27.71% |
| 1999-12-31 | CN¥651.57 Million | +99.07% |
| 1998-12-31 | CN¥327.31 Million | +21.88% |
| 1997-12-31 | CN¥268.55 Million | +89.31% |
| 1996-12-31 | CN¥141.86 Million | -- |